Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.

Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...